The present invention provides nucleic acid-containing lipid nanoparticles containing a lipid (lipid A) which has a hydrophilic unit having a single quaternary ammonium group, and three independent, optionally substituted hydrocarbon groups, a lipid derivative or fatty acid derivative of a water-soluble polymer, and a nucleic acid.

The present invention provides nucleic acid-containing lipid nanoparticles containing a lipid (lipid A) which has a hydrophilic unit having a single quaternary ammonium group, and three independent, optionally substituted hydrocarbon groups, a lipid derivative or fatty acid derivative of a water-soluble polymer, and a nucleic acid.

The invention relates to a new dialkyl tin oxide catalyst composition and its use for the synthesis of amino alkyl (meth)acrylates by transesterification from an alkyl (meth)acrylates and an amino alcohol, and especially 2-dimethylaminoethyl (meth)acrylate.

The invention also relates to polymers made with quaternized amino alkyl (meth)acrylates and use of said polymers in water treatment, sludge dewatering, papermaking process, agriculture, cosmetic and detergency composition, textile process, oil and gas recovery process such as enhanced oil recovery, fracturing, mining operation such as tailings treatment.

The invention relates to a new dialkyl tin oxide catalyst composition and its use for the synthesis of amino alkyl (meth)acrylates by transesterification from an alkyl (meth)acrylates and an amino alcohol, and especially 2-dimethylaminoethyl (meth)acrylate.

The invention also relates to polymers made with quaternized amino alkyl (meth)acrylates and use of said polymers in water treatment, sludge dewatering, papermaking process, agriculture, cosmetic and detergency composition, textile process, oil and gas recovery process such as enhanced oil recovery, fracturing, mining operation such as tailings treatment.

The invention relates to a new dialkyl tin oxide catalyst composition and its use for the synthesis of amino alkyl (meth)acrylates by transesterification from an alkyl (meth)acrylates and an amino alcohol, and especially 2-dimethylaminoethyl (meth)acrylate.

The invention also relates to polymers made with quaternized amino alkyl (meth)acrylates and use of said polymers in water treatment, sludge dewatering, papermaking process, agriculture, cosmetic and detergency composition, textile process, oil and gas recovery process such as enhanced oil recovery, fracturing, mining operation such as tailings treatment.

The invention relates to the production of (meth)acrylic esters according to a continuous process by transesterification, and in particular to the purification of a crude reaction mixture comprising a C.sub.4-C.sub.12 (meth)acrylic ester using a divided wall column employed in a particular configuration. This configuration results in a simplification of the purification process with a reduced energy consumption and a minimized content of impurities present in the purified (meth)acrylic ester. The invention also relates to a process for the production of C.sub.4-C.sub.12 (meth)acrylic ester comprising this recovery/purification process.

The invention relates to the production of (meth)acrylic esters according to a continuous process by transesterification, and in particular to the purification of a crude reaction mixture comprising a C.sub.4-C.sub.12 (meth)acrylic ester using a divided wall column employed in a particular configuration. This configuration results in a simplification of the purification process with a reduced energy consumption and a minimized content of impurities present in the purified (meth)acrylic ester. The invention also relates to a process for the production of C.sub.4-C.sub.12 (meth)acrylic ester comprising this recovery/purification process.

The present invention provides compounds of formula (I), and pharmaceutical compositions thereof. ##STR00001##

The present invention provides compounds of formula (I), and pharmaceutical compositions thereof. ##STR00001##

The invention relates to mRNA comprising lipid nanoparticles and their medical uses. The lipid nanoparticles of the present invention comprise a cationic lipid according to formula (I), (II) or (III) and/or a PEG lipid according to formula (IV), as well as an mRNA compound comprising an mRNA sequence encoding an antigenic peptide or protein. The invention further relates to the use of said lipid nanoparticles as vaccines or medicaments, in particular with respect to influenza or rabies vaccination.